| |
|
|
|
Harvard Bioscience Inc.  
|
|
2.69 0.01 (0%) |
08-23 16:00 |
|
Open: |
2.61 |
Pre close: |
2.68 |
Target:
|
3.29
|
|
High: |
2.755 |
Low: |
2.56 |
Resistance:
|
2.82
3.29
|
|
Volume: |
112,471 |
Market Cap: |
102M |
Support:
|
2.23
 1.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.63
|
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
2.50  |
Signal(12,26,9): |
0.12 |
|
MA(100): |
2.63 |
Stochastic Oscillator |
%K(14,3):
|
81.36 |
|
MA(250): |
3.49 |
%D(3): |
74.31 |
|
Average Volume(K) |
3-Month: |
57241
|
52-Week |
High:
|
6.10 |
|
10-Days: |
14983 |
Low: |
1.51 |
|
RSI |
RSI(14):
|
63.24 |
Change(%): |
-55.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.000 |
Return on Equity (ttm) |
0.6 |
Shares Out. (M) |
37.69 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
1.4 |
Shares Float (M) |
28.68 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
1.32 |
% Held by Insiders |
12.87 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
-6.1 |
% Held by Institutions |
74.11 |
|
Forward EPS |
0.260 |
Gross Profit (p.s.) |
1.777 |
Shares Short (K) |
1860 |
|
Book Value (p.s.) |
2.120 |
EBITDA (p.s.) |
0.313 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.27 |
|
Profit Margin |
-0.01 |
Operating Cash Flow
(M) |
3.83 |
P/S |
31584456.00 |
|
Operating Margin |
3.14 |
Levered Free Cash Flow
(M) |
5.01 |
P/CF |
26.47 |
|
|
|
|
|
|
